China Universal Asset Management Company’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$250K	Buy	27,890 +5,220	+23%	+$41.6K	0.02%	332
2025 Q4	$137K	Sell	22,670 -1,680	-7%	-$10K	0.01%	383
2025 Q3	$139K	Sell	24,350 -3,415	-12%	-$17.5K	0.01%	359
2025 Q2	$140K	Buy	27,765 +256	+0.9%	+$1.37K	0.01%	339
2025 Q1	$178K	Sell	27,509 -1,693	-6%	-$15.1K	0.02%	322
2024 Q4	$214K	Buy	29,202 +2,922	+11%	+$23K	0.02%	321
2024 Q3	$197K	Buy	26,280 +10,294	+64%	+$89.4K	0.02%	300
2024 Q2	$142K	Sell	15,986 -9,988	-38%	-$95.8K	0.02%	274
2024 Q1	$263K	Buy	25,974 +10,414	+67%	+$106K	0.03%	257
2023 Q4	$157K	Buy	15,560 +12,112	+351%	+$111K	0.03%	231
2023 Q3	$32.3K	Buy	3,448 +1,692	+96%	+$24.1K	0.01%	261
2023 Q2	$43.1K	Sell	1,756 -53	-3%	-$1.33K	0.01%	206
2023 Q1	$42.1K	Buy	1,809 +456	+34%	+$11.7K	0.01%	163
2022 Q4	$34.2K	Buy	1,353 +111	+9%	+$2.72K	0.01%	149
2022 Q3	$24K	Buy	+1,242	New	+$31.6K	0.01%	146